KN93, one of the CaMKII inhibitors, has been shown to have effect against arrhythmias via reduced SR Ca2+ leak, Ca2+ waves and probabilities of EADs/DADs in various settings of cardiovascular diseases.33, 34. This evidence concerns the gene CAMK2G and cardiovascular disorder.